发明名称 |
END-DEFICIENT MUTANT OF IP3 RECEPTOR PROTEIN INDUCING APOPTOSIS |
摘要 |
<p>A novel apoptosis-inducing drug which makes it possible to prevent or treat cell proliferative diseases. By expressing a mutant protein consisting of the channel domain alone of an IP3 receptor, apoptosis can be induced in a cell in which it is expressed. This mutant protein is localized on endoplasmic reticulum in a cell and makes calcium in the endoplasmic reticulum to flow toward the cytoplasm to thereby induce apoptosis of the cell.</p> |
申请公布号 |
WO2005017151(A1) |
申请公布日期 |
2005.02.24 |
申请号 |
WO2003JP14811 |
申请日期 |
2003.11.20 |
申请人 |
RIKEN;MIKOSHIBA, KATSUHIKO;HATTORI, MITSUHARU |
发明人 |
MIKOSHIBA, KATSUHIKO;HATTORI, MITSUHARU |
分类号 |
C12N15/09;A61K38/00;A61K48/00;A61P35/00;A61P43/00;C07K14/705;C12N5/10;(IPC1-7):C12N15/09 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|